Effect of hyperglycemia on stroke outcomes

Endocrine Practice

Volumn 10, Issue SUPPL. 2, 2004, Pages 34-39

  Levetan, Claresa S ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BLOOD; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; HUMAN; HYPERGLYCEMIA; INCIDENCE; LENGTH OF STAY; METABOLISM; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; STRESS; UNITED STATES;

ANIMALS; BLOOD GLUCOSE; CEREBRAL HEMORRHAGE; CEREBROVASCULAR ACCIDENT; DIABETES COMPLICATIONS; DIABETES MELLITUS; HEALTH CARE COSTS; HUMANS; HYPERGLYCEMIA; INCIDENCE; LENGTH OF STAY; RISK FACTORS; STRESS; UNITED STATES;

EID: 4644257499     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/ep.10.s2.34     Document Type: Conference Paper

References (78)

1. American Stroke Association. Impact of stroke. Available at: http://www.strokeassociation.org. Accessed March 31, 2004.
2. Centers for Disease Control and Prevention. Surveillance Report on Stroke. Vol 6 (No. 1), 1994: 14.
3. Kalache A, Aboderin I. Stroke: the global burden. Health Policy Plan.1995;10:1-21.
4. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke. 1991;22:312-318.
5. Eschwege E, Richard JL, Thibult N, et al. Coronary heart disease mortality in relation with diabetes, blood glucose, and plasma insulin levels: the Paris Prospective Study ten years later. Horm Metab Res Suppl. 1985;15:41-46.
6. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall Study. Br Med J (Clin Res Ed). 1983;287:867-870.
7. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993;16:434-444.
8. Barrett-Connor E, Khaw KT. Diabetes mellitus: an independent risk factor for stroke? Am J Epidemiol. 1988;128:116-123.
9. Palumbo PJ, Elveback LR, Whisnant JP. Neurologic complications of diabetes mellitus: transient ischemic attack, stroke, and peripheral neuropathy. Adv Neurol. 1978;19:593-601.
10. Kannel WB, McGee DI. Diabetes and cardiovascular disease: the Framingham Study. JAMA. 1979;241:2035-2038.
11. Williams LS, Rotich J, Qi R, et al. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology. 2002;59:67-71.
12. van Kooten F, Hoogerbrugge N, Naarding P, Koudstaal PJ. Hyperglycemia in the acute phase of stroke is not caused by stress. Stroke. 1993;24:1129-1132.
13. Gray CS, French JM, Bates D, Cartlidge NE, Venables GS, James OF. Increasing age, diabetes mellitus and recovery from stroke. Postgrad Med J. 1989;65:720-724.
14. Gray CS, Taylor R, French JM, et al. The prognostic value of stress hyperglycaemia and previously unrecognized diabetes in acute stroke. Diabet Med. 1987;4:237-240.
15. Pulsinelli WA, Levy DE, Sigsbee B, Scherer P, Plum F. Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus. Am J Med. 1983;74:540-544.
16. Riddle MC, Hart J. Hyperglycemia, recognized and unrecognized, as a risk factor for stroke and transient ischemic attacks. Stroke. 1982;13:356-359.
17. Levetan CS, Passaro M, Jablonski K, Kass M, Ratner RE. Unrecognized diabetes among hospitalized patients. Diabetes Care. 1998;21:246-249.
18. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87:978-982.
19. Levetan C, Dawn K, Ayala A, Ratner R. Characteristics of hospitalized patients with unrecognized diabetes. Diabetes. 1997;36(Suppl 1):183A.
20. Voll CL, Auer RN. Insulin attenuates ischemic brain damage independent of its hypoglycemic effect. J Cereb Blood Flow Metab. 1991;11:1006-1014.
21. Hamilton MG, Tranmer BI, Auer RN. Insulin reduction of cerebral infarction due to transient focal ischemia. J Neurosurg. 1995;82:262-268.
22. Husband DJ, Alberti KG, Julian DG. "Stress" hyperglycaemia during acute myocardial infarction: an indicator of pre-existing diabetes? Lancet. 1983;2:179-181.
23. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2003;26(Suppl 1):S5-S20.
24. Gonder-Frederick LA, Carter WR, Cox DJ, Clarke WL. Environmental stress and blood glucose change in insulin-dependent diabetes mellitus. Health Psychol. 1990;9:503-515.
25. Hanson CL, Henggeler SW, Burghen GA. Social competence and parental support as mediators of the link between stress and metabolic control in adolescents with insulin-dependent diabetes mellitus. J Consult Clin Psychol. 1987;55:529-533.
26. Chase HP, Jackson GG. Stress and sugar control in children with insulin-dependent diabetes mellitus. J Pediatr. 1981;98:1011-1013.
27. Hanson SL, Pichert JW. Perceived stress and diabetes control in adolescents. Health Psychol. 1986;5:439-452.
28. Vandenbergh RL, Sussman KE, Titus CC. Effects of hypnotically induced acute emotional stress on carbohydrate and lipid metabolism in patients with diabetes mellitus. Psychosom Med. 1966;28:382-390.
29. Greydanus DE, Hofmann AD. Psychological factors in diabetes mellitus: a review of the literature with emphasis on adolescence. Am J Dis Child. 1979;133:1061-1066.
30. Delamater AM, Bubb J, Kurtz SM, et al. Physiologic responses to acute psychological stress in adolescents with type 1 diabetes mellitus. J Pediatr Psychol. 1988;13:69-86.
31. Gilbert BO, Johnson SB, Silverstein J, Malone J. Psychological and physiological responses to acute laboratory stressors in insulin-dependent diabetes mellitus adolescents and nondiabetic controls. J Pediatr Psychol. 1989;14:577-591.
32. Kemmer FW, Bisping R, Steingruber HJ, et al. Psychological stress and metabolic control in patients with type I diabetes mellitus. N Engl J Med. 1986;314:1078-1084.
33. Goetsch VL, Wiebe DJ, Veltum LG, Van Dorsten B. Stress and blood glucose in type II diabetes mellitus. Behav Res Ther. 1990;28:531-537.
34. Fletcher J, Langman MJ, Kellock RK. Effect of surgery on blood-sugar levels in diabetes mellitus. Lancet. 1965;2:52-55.
35. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in non-diabetic and diabetic patients: a systematic overview. Stroke. 2001;32:2426-2432.
36. Jorgensen H, Nakayama H, Raaschou HO, Olsen TS. Stroke in patients with diabetes: the Copenhagen Stroke Study. Stroke. 1994;25:1977-1984.
37. Harris MI. Undiagnosed NIDDM: clinical and public health issues. Diabetes Care. 1993;16:642-652.
38. Weir CJ, Murray GD, Dyker AG, Lees KR. Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ. 1997;314:1303-1306.
39. Asplund K, Hagg E, Helmers C, Lithner F, Strand T, Wester PO. The natural history of stroke in diabetic patients. Acta Med Scand. 1980;207:417-424.
40. Baird TA, Parsons MW, Phanh T, et al. Persistent postroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke. 2003;34:2208-2214.
41. Alvarez-Sabin J, Molina CA, Montaner J, et al. Effects of admission hyperglycemia on stroke outcome in reper-fused tissue plasminogen activator-treated patients. Stroke. 2003;34:1235-1241.
42. Cox NH, Lorains JW. The prognostic value of blood glucose and glycosylated haemoglobin estimation in patients with stroke. Postgrad Med J. 1986;62:7-10.
43. Candelise L, Landi G, Orazio EN, Boccardi E. Prognostic significance of hyperglycemia in acute stroke. Arch Neurol. 1985;42:661-663.
44. Wass CT, Lanier WL. Improving neurologic outcome following cardiac arrest. Anesthesiol Clin North Am. 1995;13:869-903.
45. O'Neill PA, Davies I, Fullerton KJ, Bennett D. Stress hormone and blood glucose response following acute stroke in the elderly. Stroke. 1991;22:842-847.
46. Toni D, De Michele M, Fiorelli M, et al. Influence of hyperglycaemia on infarct size and clinical outcome of acute ischemic stroke patients with intracranial arterial occlusion. J Neurol Sci. 1994;123:129-133.
47. Abu-Zeid HA, Choi NW, Hsu PH, Maini KK. Prognostic factors in the survival of 1,484 stroke cases observed for 30 to 48 months. I. Diagnostic types and descriptive variables. Arch Neurol. 1978;35:121-125.
48. Finocchi C, Gandolfo C, Gasparetto B, Del Sette M, Croce R, Loeb C. Value of early variables as predictors of short-term outcome in patients with acute focal cerebral ischemia. Ital J Neurol Sci. 1996;17:341-346.
49. Power MJ, Fullerton KJ, Stout RW. Blood glucose and prognosis of acute stroke. Age Ageing. 1988;17:164-170.
50. Woo J, Lam CW, Kay R, Wong AH, Teoh R, Nicholls MG. The influence of hyperglycemia and diabetes mellitus on immediate and 3-month morbidity and mortality after acute stroke. Arch Neurol. 1990;47:1174-1177.
51. Toni D, Sacchetti ML, Argentino C, et al. Does hyperglycaemia play a role on the outcome of acute ischaemic stroke patients? J Neurol. 1992;239:382-386.
52. Kushner M, Nencini P, Reivich M, et al. Relation of hyperglycemia early in ischemic brain infarction to cerebral anatomy, metabolism, and clinical outcome. Ann Neurol. 1990;28:129-135.
53. Adams HP Jr, Olinger CP, Marler JR, et al. Comparison of admission serum glucose concentration with neurologic outcome in acute cerebral infarction: a study in patients given naloxone. Stroke. 1988;19:455-458.
54. Matchar DB, Divine GW, Heyman A, Feussner JR. The influence of hyperglycemia on outcome of cerebral infarction. Ann Intern Med. 1992;117:449-456.
55. Sacco RL, Shi T, Zamanillo MC, Kargman DE. Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community: the Northern Manhattan Stroke Study. Neurology. 1994;44:626-634.
56. Lee TH, Ryu SJ, Chen ST. The prognostic value of blood glucose in patients with acute stroke. J Formos Med Assoc. 1991;90:465-470.
57. Kiers I, Davis SM, Larkins R, et al. Stroke topography and outcome in relation to hyperglycaemia and diabetes. J Neurol Neurosurg Psychiatry. 1992;55:263-270.
58. Cazzato G, Zorzon M, Mase G, Iona LG. Hyperglycemia at ischemic stroke onset as prognostic factor. Ital J Neurol Sci. 1991;12:283-288.
59. Czlonkowska A, Ryglewicz D, Lechowicz W. Basic analytical parameters as the predictive factors for 30-day case fatality rate in stroke. Acta Neurol Scand. 1997;95:121-124.
60. Malmberg K, Norhammar A, Wedel H, Ryden L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction; long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation. 1999;99:2626-2632.
61. Scott JF, Robinson GM, French JM, O'Connell JE, Alberti KG, Gray CS. Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the Glucose Insulin in Stroke Trial (GIST). Stroke. 1999;30:793-799.
62. Demchuk AM, Morgenstern LB, Krieger DW, et al. Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke. 1999;30:34-39.
63. Bruno A, Levine SR, Frankel MR, et al. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology. 2002;59:669-674.
64. Passero S, Ciacci G, Ulivelli M. The influence of diabetes and hyperglycemia on clinical course after intracerebral hemorrhage. Neurology. 2003;61:1351-1356.
65. Levine SR, Welch KM, Helpern JA, et al. Prolonged deterioration of ischemic brain energy metabolism and acidosis associated with hyperglycemia: human cerebral infarction studied by serial 31P NMR spectroscopy. Ann Neurol. 1988;23:416-418.
66. Siesjo BK, Bendek G, Koide T, Westerberg E, Wieloch T. Influence of acidosis on lipid peroxidation in brain tissues in vitro. J Cereb Blood Flow Metab. 1985;5:253-258.
67. OuYang YB, Mellergard P, Kristian T, Kristianova V, Siesjo BK. Influence of acid-base changes on the intracellular calcium concentration of neurons in primary culture. Exp Brain Res. 1994;101:265-271.
68. Anderson RE, Tan WK, Martin HS, Meyer FB. Effects of glucose and PaO2 modulation on cortical intracellular acidosis, NADH redox state, and infarction in the ischemic penumbra. Stroke. 1999;30:160-170.
69. Olsen TS, Larsen B, Herning M, Skriver EB, Lassen NA. Blood flow and vascular reactivity in collaterally perfused brain tissue: evidence of an ischemic penumbra in patients with acute stroke. Stroke. 1983;14:332-341.
70. Steinberg HO, Tarshoby M, Monestel R, et al. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest. 1997;100:1230-1239.
71. Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet. 1994; 343:155-158.
72. Vehkavaara S, Seppala-Lindroos A, Westerbacka J, Groop PH, Yki-Jarvinen H. In vivo endothelial dysfunction characterizes patients with impaired fasting glucose. Diabetes Care. 1999;22:2055-2060.
73. Dietrich WD, Alonso O, Busto R. Moderate hyper-glycemia worsens acute blood-brain barrier injury after forebrain ischemia in rats. Stroke. 1993;24:111-116.
74. de Courten-Myers GM, Kleinholz M, Holm P, et al. Hemorrhagic infarct conversion in experimental stroke. Ann Emerg Med. 1992;21:120-126.
75. Berger L, Hakim AM. The association of hyperglycemia with cerebral edema in stroke. Stroke. 1986;17:865-871.
76. Bravata DM, Kim N, Concato J, Brass LM. Hyperglycaemia in patients with acute ischaemic stroke: how often do we screen for undiagnosed diabetes? QJM. 2003;96:491-497.
77. Levetan CS, Passaro MD, Jablonski KA, Ratner RE. Effect of physician specialty on outcomes in diabetic ketoacidosis. Diabetes Care. 1999;22:1790-1795.
78. Levetan CS, Salas JR, Wilets IF, Zumoff B. Impact of endocrine and diabetes team consultation on hospital length of stay for patients with diabetes. Am J Med. 1995;99:22-28.